Abbreviations
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FA

:   focal adhesion

FAK

:   focal adhesion kinase

ILK

:   Integrin linked kinase

IPP

:   Intergrin linked kinase-PINCH-Parvin

LRR

:   leucine rich repeat

MKK

:   Map kinase kinase

NLS

:   nuclear localization sequence

RALGEF

:   Ral Guanine nucleotide exchange factor

ROS

:   reactive oxygen species

Rsu1

:   Ras suppressor protein 1

Introduction {#s0001}
============

The IPP complex, centrally composed of integrin linked-kinase (ILK) and the adaptor proteins PINCH and parvin, is an organizing and signaling network for integrin adhesion. The composition and the functions of the widely expressed complex have been the subjects of recent comprehensive reviews.[@cit0001] In brief, the complex is organized by PINCH1 binding to ILK with PINCH1 serving as an adaptor binding to Nck2 and Rsu1. ILK links the complex to integrins via binding of its carboxyl terminal domain to β subunits of integrins and associates with the actin cytoskeleton through the binding of α parvin,[@cit0005] thus linking the complex to integrin activation, actin cytoskeleton remodeling,[@cit0006] and FA formation.[@cit0003] Additionally, a novel LIM only domain protein whose expression is elevated in metastatic tumors has been identified as a binding partner bound to the ILK pseudokinase domain.[@cit0008]

The regulatory function of PINCH in adhesion depends on its association with multiple accessory proteins.[@cit0007] PINCH1 and 2 consist of 5 LIM domains and a carboxyl terminal nuclear localization signal (NLS)[@cit0011] and both bind to an ILK ankyrin repeat through their N terminal LIM1 domain.[@cit0013] The IPP complex connects integrins to growth factor signaling through the binding of LIM4 of PINCH1 to Nck2.[@cit0016] PINCH 1 and 2 are highly homologous in LIM domains 1-4 but diverge sufficiently in LIM5 that Rsu1 binds LIM5 of PINCH1 but not PINCH2.[@cit0018] Because PINCH1 can substitute for PINCH2 in development but the not the reverse, there appears to be an essential role for PINCH1-LIM5 interaction in survival.[@cit0007] In addition to binding Rsu1, the LIM5 domain of PINCH1 has also been reported to bind protein phosphatase-1α (PP1α) as well as Thymosin β4, which maintains pools of actin monomers in cells.[@cit0020]

Rsu1 is a leucine rich repeat (LRR) protein that binds to PINCH1 with high affinity via its LRR domain[@cit0018] and co-localizes with PINCH1 at sites of focal adhesions in mammalian cells and muscle cell attachment in *Drosophila*.[@cit0018] The inhibition of PINCH-ILK or PINCH-Rsu1 interaction resulted in decreased cell spreading and reduced motility of mammalian cells.[@cit0018] In 2 large scale siRNA-mediated screens Rsu1 and PINCH1 were independently identified as proteins required for migration of the mammary epithelial cells.[@cit0027]

Rsu1 contributes to cell adhesion and spreading in part via its role in IPP function. Ectopic expression of Rsu1 in NIH 3T3 mouse fibroblasts increased cell spreading and the accumulation of actin, while shRNA-mediated Rsu1 depletion reduced cell adhesion in mammalian cells and its deletion decreased integrin-dependent functions in *Drosophila*.[@cit0018] The ectopic expression of Rsu1 cDNA also prevented Ras transformation-induced agar growth and inhibited anchorage independent growth of human tumor cell lines.[@cit0030] Rsu1 did not inhibit Ras GTPase[@cit0029] but instead altered small G protein signaling downstream of Ras including the inhibition of ROCK, Jun kinase and p38 kinase.[@cit0018]

Multiple reports correlated changes in the level of Rsu1 with altered Jun kinase activity in *Drosophila* as well as mammalian cells. Transient expression of Rsu1 in Cos1 cells inhibited growth factor-induced Jun kinase activity,[@cit0029] and the ectopic expression of Rsu1 reduced Jun kinase phosphorylation and apoptosis in both PINCH1-deleted mouse primitive endoderm cells[@cit0024] and ILK-deleted neuroprogenitor stem cells.[@cit0033] Furthermore, Rsu1 is required for the viability of *Drosophila* embryos with disrupted PINCH-ILK binding.[@cit0034] Hence, Rsu1-dependent regulation of stress induced kinase activity suggested that it could link survival signaling to conditions of perturbed adhesion.

Our recent study examining the function of Rsu1 and PINCH1 in mammary epithelial cell adhesion and EGF-induced migration demonstrated a critical role for Rsu1 and the IPP complex in proper organization of FA sites and their link to actin cytoskeleton.[@cit0035] Additionally, Rsu1 was required for EGF-dependent p38 Map kinase signaling and this function was independent of its interaction with the IPP complex. In this commentary we discuss the potential role(s) for Rsu1 in EGF-induced Map kinase kinase (MKK) activation and phosphorylation of p38 in MCF10A cells.

Rsu1 and PINCH1 Contributions to Focal Adhesions and Caveoli are Required for Migration {#s0002}
=======================================================================================

Investigation of the requirement for Rsu1-PINCH1 interaction in the regulation of cell adhesion, spreading and migration in MCF10A mammary epithelial cells suggested that both proteins contribute to similar functions. Previous studies established that Rsu1-PINCH1 binding was required for cell adhesion and PINCH1 functionality.[@cit0003] Our study confirmed that independent depletion of Rsu1 and PINCH1 resulted in decreased cell adhesion, spreading and migration in MCF10A cells.[@cit0035] This change appeared to be a direct consequence of a disruption in the organization of focal adhesion sites as demonstrated by the altered distribution and localization of the FA proteins paxillin, vinculin, talin, and β1 integrin as well as a reduction in the levels of phosphorylated FAK (Tyr 397). Most phenotypes associated with decreased levels of either Rsu1 or PINCH1 were more severe in the PINCH1-depleted cells. As observed previously, the depletion of Rsu1 caused significant reduction in PINCH1, while PINCH1 depletion resulted in only a modest reduction in Rsu1, implying that Rsu1 functions in the regulation of PINCH1 stabilization and that the phenotype observed in Rsu1-depleted cells may be partially due to decreased PINCH1 levels.[@cit0018]

While ILK expression was slightly affected by Rsu1 reduction, PINCH1 depletion significantly decreased ILK levels. Phenotypes previously observed in ILK deficient cells were noted in Rsu1- and PINCH1-depleted cells including the release of caveolin from the FAs[@cit0038] and the localization and distribution of β1 integrin in endosome like structures. These changes were primarily linked to loss of PINCH1-ILK function. Similarly, Rsu1- and PINCH1-depleted cells displayed a loss of actin stress fibers. However, PINCH1 depletion also caused increased phosphorylation of actin regulatory proteins VASP and cofilin. The loss of actin stress fibers was likely the outcome of defective ILK-parvin association resulting from fewer ILK molecules available for parvin binding, which is critical for actin mediated functions in adhesion.[@cit0004]

While most of the phenotypes exhibited by Rsu1-depleted cells were not as severe as those lacking PINCH1, cell spreading was equally affected by Rsu1 or PINCH1 depletion. Rac activity has been linked to spreading, and both Rsu1 and PINCH1 depleted cells exhibited decreased constitutive Rac1 activity. However, EGF stimulation restored Rac-GTP regardless of the level of Rsu1 or PINCH1 and a recent report demonstrated that Rac is not required for spreading of fibroblasts,[@cit0042] hence, it is unlikely that the Rac defect alone impaired spreading in Rsu1 or PINCH1 deficient cells. Reconstitution of Rsu1-depleted cells with a Rsu1 mutant (N92D) that fails to bind PINCH1 restored spreading in MCF10A cells otherwise defective due to the depletion of the endogenous Rsu1, thus implicating a Rsu1-dependent event controlling spreading. ILK, but not Rac, is required for lumen formation by mammary epithelial cells.[@cit0043] The formation of acini with luminal clearance by N92D-Rsu1 cells supported the idea that the inhibition of Rac activation resulting from absence of Rsu1-PINCH1 interaction in MCF10A cells was not critical.

Expression of the N92D-Rsu1 protein in Rsu1-depleted cells resulted in small FAs compared to wt-Rsu1, and only wt-Rsu1 restored migration, indicating that binding of Rsu1 to PINCH1-ILK-parvin is required for the proper regulation of adhesion and migration. Because the size of FAs correlates with migratory activity,[@cit0044] the reduced size of FA sites in cells expressing only N92D-Rsu1 likely contributed to reduced migration. In support of this analysis, Rsu1-PINCH1-ILK interaction is required for rescue of muscle cell attachment migration defects in a myosin phosphatase hypercontraction mutant of *Drosophila*.[@cit0045]

Rsu1 is Required for EGF-induced Activation of the p38 Map Kinase Signaling {#s0003}
===========================================================================

Previous work demonstrated that modulation of Rsu1 levels altered ROCK,[@cit0031] Jun kinase and p38 Map kinase activity.[@cit0018] The exact mechanism by which this occurred, and whether it resulted from alterations in IPP functions, is not entirely clear. It is worth noting that while Rsu1 expression blocked Ras-dependent transformation of NIH3T3 fibroblasts as measured by agar growth, Rsu1 expression did not block v-src-induced transformation of the same cells.[@cit0030] The differences between v-src and Ras transformation include the mechanisms by which they activate PI-3-kinase signaling[@cit0047] and the Ras-dependent increase in Jun kinase which is required for Ras transformation.[@cit0049] In addition, ROS elevation leading to p38 activation and RALGEF stimulation are unique changes that occur in Ras-transformed but not src-transformed cells.[@cit0051] Hence, the reduction in Jun kinase and the increase in p38 signaling due to Rsu1 expression may be mechanistically linked to the Rsu1 specificity for inhibition of Ras transformation.

p38 Map kinase signaling is required for cell spreading and migration in response to diverse signals[@cit0054] and EGF-dependent MCF10A cell migration was blocked by inhibitors of p38 Map kinase. The depletion of Rsu1, but not PINCH1, blocked EGF- induced p38 phosphorylation in MCF10A cells suggesting a unique function for Rsu1 in activation of this pathway. The wt-Rsu1, and also the N92D-Rsu1 mutant, restored EGF-induced p38 activity in Rsu1 depleted cells supporting the finding of an Rsu1 function independent of IPP signaling. Furthermore, the constitutive and inducible p38 phosphorylation and the recovery of cell spreading resulting from expression of the N92D-Rsu1 mutant suggested that Rsu1 contributes to cell spreading by promoting signaling through the p38 Map kinase. Data from several studies support a role for p38 in actin cytoskeletal regulation and spreading. For example, WAVE3 promotes cell motility via the p38 Map kinase pathway and MMP expression[@cit0058] and signaling through p38 is required for actin polymerization and cell migration in smooth muscle cells[@cit0056] and intestinal epithelial cells.[@cit0057] The treatment of oligodendrocytes with thymosin β4, a PINCH1 binding and actin regulatory protein, also increased p38 Map kinase activity[@cit0059] and ILK dependent activation of p38 regulated actin polymerization in vascular smooth muscle cells.[@cit0060] While these studies did not probe for a link to Rsu1 it may have been a contributing factor to the alteration in p38 Map kinase.

p38 Map kinase is an important regulator of cell death and survival under conditions of stress, including detachment-induced stress that occurs during acini formation in MCF10A cells. In this process activated p38 is thought to be essential for apoptotic signals required for luminal clearance.[@cit0061] In cells depleted of Rsu1 the defect in p38 activation was restricted to an EGF-induced activation pathway. Hence, the detachment of Rsu1-depleted MCF10A cells resulted in p38 phosphorylation and allowed formation of acini exhibiting luminal clearance.

There are a number of ways in which p38 signaling participates in essential cellular processes. Activation of p38 is detected in spreading and migration as noted above. Also, phosphorylated p38 can function to activate checkpoint controls that allow cell survival under conditions of stress in MCF10A cells.[@cit0062] p38 and its target ATF2 were required for survival in embryonic liver [@cit0063] and some leukemic cells.[@cit0064] Several lines of evidence also support a survival function for Rsu1. In *Drosophila* embryos with disruption of PINCH-ILK binding the depletion of Rsu1 resulted in lethality independent of PINCH1 localization or stabilization.[@cit0034] The depletion of PINCH1 in mouse primitive endoderm cells resulted in a decrease of Rsu1 concomitant with increased Jun kinase and Bax activation and reduced Bcl-2 levels, and the introduction of Rsu1 decreased Jun kinase activity.[@cit0024] It is not clear if Rsu1 functions to regulate p38 in these systems but it could contribute to survival by activating a p38 checkpoint control. The elevated levels of p38 activation displayed by the Rsu1 mutant and the lack of p38 activity exhibited by the Rsu1-depleted cells supports a function for Rsu1 in promoting cell survival through a p38 mediated mechanism. In addition, this provides an explanation for the inability of Rsu1 depleted MC10A cells to survive indefinitely.

There are several relevant control points for p38 phosphorylation including its activation by MKK4 or MKK3 and MKK6. In MCF10A cells, detachment-induced p38 activation occurs via phosphorylation primarily by MKK6[@cit0061] but this pathway is poorly activated by EGF stimulation in these cells ([**Fig. 1**](#f0001){ref-type="fig"}). Hence, the less adherent N92D-Rsu1 expressing cells, which exhibit constitutive p38 phosphorylation, might be expected to have MKK6 activation as a result of decreased FAs and FA function. In 293T cells, which can survive without strong adhesion to substrate, the disruption of Rsu1-PINCH1 association led to reduced adhesion and enhanced p38 and Jun kinase activation.[@cit0018] Figure 1.siRNA-mediated depletion of Rsu1 blocks activation of MKK4 in MCF10A cells. MCF10A cells transfected with a Rsu1 specific or a negative control siRNA were stimulated with EGF (10ng/ml) at 96 hours post transfection and lysates were harvested and examined by western blotting as described previously.[@cit0035] Antibodies for the expression of proteins include: phospho-MKK4 Ser257 (Cell Signaling Technology \#4514), MKK4 (Santa Cruz Biotechnology \#166168), phospho-MKK3 Ser189/MKK6 Ser207 (Cell Signaling Technology \#9231) Tubulin (Santa Cruz Biotechnology \#8035) was used as loading control.

However, reconstitution of Rsu1 depleted MCF10A cells with N92D-Rsu1 allowed p38 phosphorylation by EGF suggesting that another pathway, likely MKK4, is activated by EGF. The results in [**Figure 1**](#f0001){ref-type="fig"} clearly demonstrate that siRNA-mediated depletion of Rsu1 blocked the stimulation of MKK4 phosphorylation in response to EGF in MCF10A cells. Hence, this indicates that the loss of Rsu1 has an impact on p38 Map kinase signaling via the inhibition of MKK4 activation. Because MKK4 can activate both p38 and Jun kinase depending on cell specific stimulatory and regulatory context, it may be the critical node for Rsu1 regulation of these kinases ([**Fig. 2**](#f0002){ref-type="fig"}). Figure 2.The absence of Rsu1-PINCH1 binding alters MKK4 and p38 Map kinase activation in MCF10A cells. (Left) Expression of either endogenous Rsu1 protein or wt-Rsu1 in the absence of endogenous protein allows activation of MKK4 and phosphorylation of p38 Map kinase in MCF10A cells. (Middle) In cells that are detached from substrate, or depleted of Rsu1, integrin engagement and focal adhesion formation are reduced or absent. This results in a block in the activation of MKK4, but MCF10A cell detachment leads to the activation of p38 by MKK6. (Right) The reconstitution of Rsu1-depleted cells with N92D-Rsu1 does not completely restore FA formation but it does promote MKK4 activation.

MKK4 is well characterized as tumor suppressor in many solid tumors including breast, ovarian and liver. In addition to MKK4 deletion or mutation in tumors, the loss of Rsu1 activity may interfere with MKK4 signaling and thereby contribute to the loss of tumor suppressor activity. Genomic deletions in Rsu1 have been detected in both a subset of human hepatocellular carcinomas as well as in gliomas[@cit0065], and according to recent reports the depletion of Rsu1 in prostate tumors occurs via stroma-produced miRs.[@cit0067] Hence, the connection of Rsu1 to MKK4, p38, Jun kinase and ATF2 may be a potential regulatory event in tumorigenesis.

Conclusions {#s0004}
===========

Our recent report identified a defect in the EGF-induced activation of the p38 Map kinase in MCF10A cells depleted of Rsu1. The reconstitution of MCF10A with wt-Rsu1 restored p38 Map kinase activity, FA formation, spreading and migration. In contrast, a mutant of Rsu1 that fails to bind to PINCH1 and the IPP complex restored only responsiveness to EGF-induced action of p38 but not complete formation of FAs or functions dependent on intact FAs. However, the restoration of p38 signaling coincided with functional cell spreading. Collectively, these results confirm a critical role for Rsu1 and IPP complex interaction in proper formation of FA sites and actin cytoskeleton remodeling. More importantly our findings revealed a unique role for Rsu1 in cell spreading and p38 activation that is independent from IPP signaling. Modulation of signaling at the level of MKK4, a common Jun kinase and p38 Map kinase activator, could account for the divergent results obtained following Rsu1 depletion or ectopic expression. Data from several sources suggest that MKK4 may be a critical molecule in this pathway and Rsu1 depletion blocks MKK4 activation by EGF in MCF10A cells. Hence, our current efforts are directed at understanding how Rsu1 differentially regulates p38 and Jun kinase activity and how this regulation is related to adhesion and survival.
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